Position in IRWD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,239,379
+$1,625,702 QoQ
Shares Held
1,006,979
+35.2% QoQ
Ownership
0.609%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 212 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. IRWD ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in IRWD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,239,379 | 1,006,979 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,613,677 | 744,638 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,299,412 | 385,583 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $30,458 | 23,251 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,739 | 23,251 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $449,833 | 306,011 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,369,913 | 309,236 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,289,756 | 313,048 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,087,538 | 320,175 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,711,770 | 311,340 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $326,931 | 28,578 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $190,249 | 19,756 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $246,176 | 23,137 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $240,002 | 22,814 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $247,997 | 20,016 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $210,379 | 20,307 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $163,541 | 14,184 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $151,349 | 12,031 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $117,741 | 10,098 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||